Search Results
Oct 31, 2025, 08:00 ET Servier's VORANIGO® (vorasidenib) Receives Prestigious 2025 Prix Galien USA Award
today announced that VORANIGO® (vorasidenib) has been awarded The Galien Foundation's 2025 Prix Galien USA Award for Best Product for Orphan/Rare Disease. The award was presented during a ceremony at the American Museum of Natural History in New York on October 30, 2025.
More news about: Servier Pharmaceuticals
Oct 31, 2025, 07:49 ET AbbVie Reports Third-Quarter 2025 Financial Results
(BPDCN). The submission is based on data from the Phase 1/2 CADENZA trial, a global study evaluating the safety and efficacy of PVEK in BPDCN. BPDCN is a rare and aggressive blood cancer with significant need for innovative treatment options for both newly diagnosed patients and for those whose prior treatments
More news about: AbbVie
Oct 31, 2025, 07:00 ET Marengo to Present Late-Breaking Clinical Oral Abstract at SITC 2025 Highlighting Initial Monotherapy Activity of Invikafusp Alfa in Tissue-Agnostic, TMB-High Advanced Cancers
preliminary efficacy of invikafusp alfa as a monotherapy in biomarker-selected patients with advanced antigen-rich solid tumors, including PD-1 refractory and rare tumor types. The trial consists of two parts: Phase 1 dose escalation and Phase 2 dose expansion. For more information, visit
More news about: Marengo Therapeutics
Oct 31, 2025, 06:42 ET Weekly Recap: 12 Tech Press Releases You Need to See
Nauticus Robotics Secures $250 Million Equity Facility and Launches Strategic Initiative to Enter Deep-Sea Rare Earth Mineral Exploration Market This new initiative is part of Nauticus' broader strategy
More news about: PR Newswire
Oct 31, 2025, 06:00 ET Oddities and Curiosities Expo Announces 2026 Tour Across U.S. and Canada
WHAT TO EXPECT Shop the strange: Attendees can browse and shop for rare and unique items, including taxidermy, preserved animal specimens, original horror and Halloween-inspired artwork, antiques, metaphysical accoutrements,
More news about: Oddities & Curiosities Expo
Oct 30, 2025, 23:11 ET Iozera Enters Agreement to Acquire Fully Operational Houston Data Center, Expanding AI-as-a-Service Infrastructure
with a dedicated, trained human workforce that supervises, labels, and refines every model in production. This "humans-in-the-loop" architecture is rare in modern AI infrastructure and ensures every deployment learns, adapts, and aligns in real time. Unlike
More news about: Iozera.ai
Oct 30, 2025, 20:00 ET CCTV4：The documentary Homeland Restored: 80 Years Since Taiwan's Recovery from Japanese Occupation is set to premiere
and abroad. As well as filming a wealth of invaluable historical relics, they also delved into archival documents, diaries, letters and obtained many rare video materials - many of which will be revealed to the public for the first time come the airing of the series. The documentary
More news about: CCTV4
Oct 30, 2025, 20:00 ET CCTV4：The documentary Homeland Restored: 80 Years Since Taiwan's Recovery from Japanese Occupation is set to premiere
and abroad. As well as filming a wealth of invaluable historical relics, they also delved into archival documents, diaries, letters and obtained many rare video materials - many of which will be revealed to the public for the first time come the airing of the series. The documentary
More news about: CCTV4
Oct 30, 2025, 18:34 ET Dr. Antoanella Calame Named "2025 Top Doctor"
sixth consecutive year that Dr. Calame has been recognized as a Top Doctor and notably, she is the only dermatopathologist to receive this honor. This rare distinction reflects her unwavering commitment to excellence in patient care, medical education, and diagnostic precision. For
More news about: Compass Dermatopathology
Oct 30, 2025, 17:31 ET Atypical Teratoid/Rhabdoid Tumor Treatment Market Shows Promising CAGR During the Forecast Period (2025-2034) with Growing Clinical Trials and R&D Initiatives | DelveInsight
The company is currently conducting Phase I dose-escalation trials to assess the safety and pharmacokinetics of ONC206 in patients with recurrent and rare primary central nervous system tumors, including atypical teratoid/rhabdoid tumors. In April 2025, Jazz Pharmaceuticals completed its acquisition of
More news about: DelveInsight Business Research, LLP
Oct 30, 2025, 17:15 ET Ramaco and U. S. Department of Energy's (DOE) National Energy Technology Laboratory (NETL) Execute Far-Reaching Strategic Agreement on Rare Earths and Critical Minerals
our estimates of rare earth and critical minerals at the Brook Mine are reported as in-place inferred resources. Rare earth and critical minerals is a new initiative for us and, as such, has required and will continue to require us to make significant investments to build out our rare earth capabilities.
More news about: Ramaco Resources, Inc.
Oct 30, 2025, 15:20 ET Simplicity Patterns Relaunches Under Independent, Employee-Led Management
In 2026, Simplicity will introduce highly anticipated new patterns from Gunne Sax, as well as its "Vintage Vault", carefully curating and reissuing rare pattern treasures from extensive fashion archives. "We're grateful to our entire community for their patience as we've been preparing
More news about: Simplicity Patterns Inc.
Oct 30, 2025, 15:15 ET Luxury (High End) Lighting Market to Reach USD 35,220.96 million by 2032, Growing At An 6.40% CAGR - Credence Research
often relies on a global supply chain for specialized and high-quality raw materials, from Italian marble and Murano glass to high-purity metals and rare woods. These supply chains can be complex and vulnerable to disruption from geopolitical events, trade tariffs, and logistical challenges. Any interruption
More news about: Credence Research Inc.
Oct 30, 2025, 13:52 ET RightOfTheDot to Host NamesCon Global 2025 Live & Online Domain Auction Featuring Tokens.com and Omegle.com
and authentication, making this domain ideal for a financial platform, DeFi gateway, or tokenized marketplace. Tokens·com represents a rare, universal brand perfectly aligned with the future of digital finance and Web3 innovation.
More news about: RightOfTheDot
Oct 30, 2025, 13:46 ET New Book Lifts Curtain on America's Secret Fentanyl War Against the Sinaloa Cartel and Chinese Accomplices
fentanyl networks — integrating law enforcement, financial, intelligence, and diplomatic pressure under one strategy. He describes a rare bipartisan effort spanning the Trump and Biden Administrations, but warns that the fight isn't over. "We
More news about: DEF CON Franklin
Oct 30, 2025, 12:59 ET PACSUN DROPS NEW EXCLUSIVE DENIM COLLECTION IN PARTNERSHIP WITH SELENA GOMEZ'S THE RARE IMPACT FUND
About the Rare Impact Fund The Rare Impact Fund was founded by Selena Gomez in 2020 as part of her commitment to addressing mental health and self-acceptance. One percent of all Rare Beauty by Selena Gomez sales are donated to the Rare Impact Fund, which supports
More news about: Pacsun
Oct 30, 2025, 12:37 ET Black-Owned Gin Breaks Through: The Old G Wins "Best Gin in Show" at Global Spirit Awards
are Black, and only about 175 spirits brands nationwide are Black-owned, according to Forbes and Black Spirits Legacy. The Old G's recognition is a rare breakthrough in an industry where Black entrepreneurship and influence remain dramatically underrepresented. The Old G isn't
More news about: The Old G
Oct 30, 2025, 12:22 ET WWEX Group Appoints Arjun Srinivasan as Senior Vice President of AI & Data Science
accelerate the momentum we've built in putting real, actionable AI solutions into production," said Joel Clum, Chief Operating Officer at WWEX Group. "It's rare to find individuals that have the blended skillset of data science and AI, with the experience of delivering real outcomes with AI solutions – we're
More news about: WWEX Group
Oct 30, 2025, 12:00 ET ZOMBIE FORECLOSURE AND VACANCY RATES CREEP DOWN
12.3 percent to 272); Michigan (down 11.3 percent to 63); and Iowa (down 9.3 percent to 107). Vacancies rare in New England statesThe states with the highest overall home vacancy rates in the fourth quarter were Oklahoma (2.4 percent); Kansas (2.3
More news about: ATTOM
Oct 30, 2025, 11:04 ET Veteran Corporate Communications, Government Relations and Marketing Executives Form CorpBridge Advisors
geopolitical risk advisory and provides counsel to clients from the financial services, fintech, consumer goods, media and technology sectors. Rare in the industry, CorpBridge Advisors possesses both in-house and firm experience at the most senior levels. The result is deeply knowledgeable and practical
More news about: CorpBridge Advisors
Oct 30, 2025, 10:18 ET Competitive Landscape of Obesity Therapeutics Market Enters High-Growth Phase, Fueled by GLP-1 Surge and Expanding Oral Treatments | DataM Intelligence
A specialist biotech focused on melanocortin-4 receptor (MC4-R) agonists for rare genetic obesity conditions, Rhythm stands out with its differentiated mechanism. Rhythm's pipeline includes late-stage assets
More news about: DataM Intelligence 4 Market Research LLP
Oct 30, 2025, 10:10 ET ACCUTRON BRINGS BACK THE HUM: THE TUNING FORK WATCH RETURNS TO HISTORY
impossible. The new proprietary Tuning Fork movement revives the spirit of the original through a modern lens, offering collectors and enthusiasts the rare opportunity to experience a piece of horological history. "The launch of this iconic movement is not just a tribute to the innovation
More news about: Accutron
Oct 30, 2025, 10:00 ET Apiphani Acquires Tradeoff Software, Welcoming Founder Braden Ericson to Lead Product & Engineering
team amplify what we're building at apiphani — technically, culturally, and in how they think about solving problems," said Folkers. "They deliver that rare ability to see around corners, and to build products with that perspective in mind. I couldn't imagine a better partner to help bring our vision for
More news about: APIPHANI, INC
Oct 30, 2025, 09:40 ET Disrupting Healthcare: Dr. Jay Greenstein's AI Rewards Patients for Healing Themselves
and outcomes. With decades of experience as a chiropractor, researcher, consultant, and entrepreneur, Dr. Greenstein brings a rare 360° perspective on the challenges and opportunities within the U.S. healthcare system. His deep understanding of patient care, policy, and technology
More news about: Disruption Interruption
Oct 30, 2025, 09:00 ET Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders
About RARE-X RARE-X is the research program of Global Genes. RARE-X provides a highly scalable approach for rare disease data collection, delivered in partnership with patient advocacy groups. RARE-X's global footprint includes more
More news about: RARE-X